Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wenqing Wang

Showing results (391-400 of 399) with videos related to

Pageof 40
Sort By:
You have reached the last page of results.This site can display upto 399 results.
Frontiers in Oncology|October 29, 2020
Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With MedulloblastomaJing Yan, Lei Liu, Weiwei Wang, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2021
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG SurveyChen Li, Xin Wang, Lan Wang, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysisWeiming Han, Lan Wang, Chen Li, et al.
Science Immunology|May 2, 2025
Distinct type I and II interferon responses direct cortical and medullary thymic epithelial cell developmentAbdulvasey Mohammed, Wenqing Wang, Martin Arreola, et al.
The Oncologist|February 22, 2020
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled StudyWei Deng, Jinsong Yang, Wenjie Ni, et al.
Frontiers in Oncology|September 28, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II TrialXin Wang, Xiaolin Ge, Xiaomin Wang, et al.
Journal of the American Academy of Dermatology|September 27, 2024
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Fuqiu Li, Xiaodong Bi, et al.
JAMA Network Open|May 17, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialXin Wang, Weiming Han, Wencheng Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trialJunqiang Chen, Xiao Chang, Wenyang Liu, et al.
Pageof 40

Showing results (391-400 of 399) with videos related to

Sort By:
Pageof 40
You have reached the last page of results.This site can display upto 399 results.
Frontiers in Oncology|October 29, 2020
Radiomic Features From Multi-Parameter MRI Combined With Clinical Parameters Predict Molecular Subgroups in Patients With MedulloblastomaJing Yan, Lei Liu, Weiwei Wang, et al.
Acta Oncologica (Stockholm, Sweden)|April 1, 2021
Clinical practice and outcome of radiotherapy for advanced esophageal squamous cell carcinoma between 2002 and 2018 in China: the multi-center 3JECROG SurveyChen Li, Xin Wang, Lan Wang, et al.
Therapeutic Advances in Medical Oncology|November 3, 2022
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysisWeiming Han, Lan Wang, Chen Li, et al.
Science Immunology|May 2, 2025
Distinct type I and II interferon responses direct cortical and medullary thymic epithelial cell developmentAbdulvasey Mohammed, Wenqing Wang, Martin Arreola, et al.
The Oncologist|February 22, 2020
Postoperative Radiotherapy in Pathological T2-3N0M0 Thoracic Esophageal Squamous Cell Carcinoma: Interim Report of a Prospective, Phase III, Randomized Controlled StudyWei Deng, Jinsong Yang, Wenjie Ni, et al.
Frontiers in Oncology|September 28, 2020
S-1-Based Chemoradiotherapy Followed by Consolidation Chemotherapy With S-1 in Elderly Patients With Esophageal Squamous Cell Carcinoma: A Multicenter Phase II TrialXin Wang, Xiaolin Ge, Xiaomin Wang, et al.
Journal of the American Academy of Dermatology|September 27, 2024
Efficacy and safety of vunakizumab in moderate-to-severe chronic plaque psoriasis: A randomized, double-blind, placebo-controlled phase 3 trialKexiang Yan, Fuqiu Li, Xiaodong Bi, et al.
JAMA Network Open|May 17, 2023
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical TrialXin Wang, Weiming Han, Wencheng Zhang, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
Long-term outcomes of S-1-based chemoradiotherapy in inoperable elderly patients with esophageal carcinoma: A multicenter, randomized, phase III clinical trialJunqiang Chen, Xiao Chang, Wenyang Liu, et al.
Pageof 40